Opportunity Information: Apply for RFA NS 23 027

Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional) is an NIH/NINDS funding opportunity (RFA-NS-23-027; CFDA 93.853) that supports large, tightly coordinated team-science projects aimed at ambitious neuroscience questions within the mission of the National Institute of Neurological Disorders and Stroke. This announcement is a reissue of an earlier FOA (RFA-NS-22-011) that was updated to align with NIH Data Management and Sharing Policy (DMSP) requirements; the reissue does not change the application due dates or where the application is reviewed. The award mechanism is the RM1, and clinical trials may be proposed but are not required, meaning teams can submit either basic, translational, or clinically oriented projects as long as the work fits NINDS priorities.

A defining feature of COMBINE is that it is built for true integration across disciplines and investigators. Applications must be led by a multi-PI team of at least three and no more than six Program Directors/Principal Investigators, organized around a single, shared scientific goal that cannot be achieved by one lab working alone. The FOA emphasizes collaboration that creates synergy, with active coordination and managed team interactions, rather than a loose federation of labs. In practical terms, NINDS is looking for projects where each part of the science depends on and strengthens the others, with shared strategy, shared milestones, and a coherent narrative that demonstrates why the team structure is essential to success.

The program is also clearly positioned as different from the NINDS P01 model. Instead of multiple semi-independent subprojects bundled together, COMBINE expects one cohesive and well-integrated research plan with a singular focus, one unified set of specific aims, and a single consolidated budget (not a set of subproject budgets). The intent is to fund bold, challenging research that has a realistic path to major advances, and teams are encouraged to define transformative objectives that can produce concrete, compelling outcomes within a five-year project period. In other words, the application should read like one high-impact project executed by a coordinated leadership group, not several parallel projects sharing an umbrella topic.

Eligibility is broad and includes many common applicant types such as public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (other than small businesses), small businesses, and various levels of government (state, county, city/township, special districts), as well as independent school districts and public housing authorities/Indian housing authorities. Federally recognized Native American tribal governments are eligible, and the FOA also highlights additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, Tribally Controlled Colleges and Universities, faith-based or community-based organizations, eligible federal agencies, regional organizations, tribal governments that are not federally recognized, and U.S. territories or possessions. At the same time, the FOA draws clear lines on foreign participation: non-domestic (non-U.S.) entities and non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply, but foreign components are permitted when they meet the NIH definition in the NIH Grants Policy Statement.

Key administrative details provided include that the opportunity is categorized as a discretionary grant in the health area, with an original closing date of 2024-10-08 and a creation date of 2023-05-15. The award ceiling and expected number of awards are not specified in the supplied listing. Overall, COMBINE is best understood as NINDS support for high-risk/high-reward, interdisciplinary neuroscience led by a small leadership coalition, where the strongest applications will show genuine interdependence among the approaches, strong coordination plans, and a clear five-year arc toward outcomes that would be difficult to reach through conventional single-lab or loosely coordinated multi-project structures.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Collaborative Opportunities for Multidisciplinary, Bold, and Innovative Neuroscience (COMBINE) (RM1 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853.
  • This funding opportunity was created on 2023-05-15.
  • Applicants must submit their applications by 2024-10-08. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA NS 23 027

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: VCID Center Without Walls for Understanding and Leveraging Small Vessel Cerebrovascular Disease Mechanisms in ADRD (R01 - Clinical Trial Not Allowed)

Previous opportunity: U.S. Mission to the EU PAS Annual Program Statement

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA NS 23 027

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA NS 23 027) also looked into and applied for these:

Funding Opportunity
Understanding Gene-Environment Interactions in Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 021

Funding Number: RFA AG 24 021
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed) Apply for RFA AI 23 032

Funding Number: RFA AI 23 032
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,500,000
Preclinical Studies to Characterize the Impact of Toxicants on Brain Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 023

Funding Number: RFA AG 24 023
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,250,000
Quantifying the Impact of Environmental Toxicants on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Risk in Cohort Studies (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 022

Funding Number: RFA AG 24 022
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
Significance of Clonal Hematopoiesis (CH) in Aging Humans (R01 Clinical Trial Not Allowed)? Apply for RFA AG 24 038

Funding Number: RFA AG 24 038
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)? Apply for RFA AG 24 036

Funding Number: RFA AG 24 036
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Health Information Systems (HIS) Activity Apply for 72052123RFI00001

Funding Number: 72052123RFI00001
Agency: Haiti USAID-Port Au Prince
Category: Health
Funding Amount: Case Dependent
Assessment of TBI-related ADRD Pathology Related to Cognitive Impairment and Dementia Outcomes (U01 - Clinical Trial Not Allowed) Apply for RFA NS 24 003

Funding Number: RFA NS 24 003
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,300,000
Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed) Apply for PAR 23 211

Funding Number: PAR 23 211
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed) Apply for PAR 23 212

Funding Number: PAR 23 212
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
NIMHD Centers of Excellence in Investigator Development and Community Engagement (P50 - Clinical Trial Optional) Apply for RFA MD 23 011

Funding Number: RFA MD 23 011
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Accelerating Behavioral and Social Science through Ontology Development and Use: Dissemination and Coordination Center (U24) Clinical Trial Not Allowed Apply for PAR 23 181

Funding Number: PAR 23 181
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 23 001

Funding Number: RFA AA 23 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,150,000
Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) Apply for RFA AA 23 002

Funding Number: RFA AA 23 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,250,000
NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required) Apply for PAR 23 209

Funding Number: PAR 23 209
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Collaborative Clinical Vision Research Project: Resource Center Grant (UG1 Clinical Trial Required) Apply for PAR 23 201

Funding Number: PAR 23 201
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: National Primate Research Centers (P51) (Clinical Trials Not Allowed) Apply for PAR 23 126

Funding Number: PAR 23 126
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Collaborative Clinical Vision Research Project: Coordinating Center Grant (UG1 Clinical Trial Required) Apply for PAR 23 204

Funding Number: PAR 23 204
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Enhancing Use of Harmonized Cognitive Assessment Protocol Data?(R01 Clinical Trial Not Allowed) Apply for RFA AG 24 032

Funding Number: RFA AG 24 032
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
NIAID Clinical Trial Planning Grant (R34 Clinical Trial Not Allowed) Apply for PAR 23 206

Funding Number: PAR 23 206
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 23 027", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: